Sarah Reeve
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Sarah Reeve has a total of 60 co-authors. Here are the top co-authors by number of shared publications:
- Daniel Freeman
University of Oxford
11 shared publications Bryony Sheaves
Department of Experimental Psychology, University of Oxford
4 shared publications- Bryony Sheaves
Department of Psychiatry, University of Oxford, Oxford, UK
4 shared publications - Alecia Nickless
School of Chemistry, University of Bristol, Bristol, UK
3 shared publications - Felicity Waite
Department of Experimental Psychology, University of Oxford, Oxford, UK
3 shared publications - Alvaro Barrera
Department of Psychiatry, University of Oxford, Oxford, UK
2 shared publications
Latest Publications
- Open Access
- 2 July 2026
- Published by Oxford University Press (OUP) in SLEEP Advances
- Vol. 7 (3)
Development and validation of the Tiredness Identification Index (TIDI): a combined scale for the assessment of fatigue and sleepiness
Study Objectives: Tiredness is a common presentation composed of sleepiness (propensity towards sleeping) and fatigue (feelings of physiological exhaustion). Differentiating between these presentations is important for diagnosis and management. The current study reports on the development and validation of an integrated measure of tiredness (Tiredness Identification Index - TIDI) incorporating assessment of sleepiness and fatigue, and the relationship of the measure with sleep and mental health outcomes. Method: A sample of 6706 adult participants responded to a pool of sleepiness and fatigue items. Regularised structural equation modelling and confirmatory factor analysis were used to refine the items and factor structure based on convergence against validation measures of fatigue and sleepiness. Regression analyses were then applied to test relationships of the sleepiness and fatigue factors with sleep, mental health, and wellbeing variables. Results: An 8-item scale was developed, composed of a sleepiness (TIDI-sleepiness) and fatigue (TIDI-fatigue) factor with divergent and convergent validity, alongside a general tiredness factor. Higher TIDI-sleepiness was associated with increased apnoea risk and shorter sleep duration, whereas TIDI-fatigue was associated with increased insomnia and reduced sleep efficiency. Controlling for TIDI-sleepiness, TIDI-fatigue was associated with increased depression, anxiety, reduced well-being, and lower physical activity. Increased TIDI-sleepiness and TIDI-fatigue were both associated with paranoia and hallucinations. Conclusions: The results indicate that the TIDI can be used as a brief scale to measure and differentiate fatigue and sleepiness, particularly in non-clinical populations and for research purposes. Assessment of its validity in discriminating fatigue and sleepiness in relevant clinical sleep, mental, and physical health populations should be a focus of future research.
- 2 July 2026
- Published by Oxford University Press (OUP) in SLEEP Advances
- Vol. 7 (3)
Open AccessDevelopment and validation of the Tiredness Identification Index (TIDI): a combined scale for the assessment of fatigue and sleepiness
Study Objectives: Tiredness is a common presentation composed of sleepiness (propensity towards sleeping) and fatigue (feelings of physiological exhaustion). Differentiating between these presentations is important for diagnosis and management. The current study reports on the development and validation of an integrated measure of tiredness (Tiredness Identification Index - TIDI) incorporating assessment of sleepiness and fatigue, and the relationship of the measure with sleep and mental health outcomes. Method: A sample of 6706 adult participants responded to a pool of sleepiness and fatigue items. Regularised structural equation modelling and confirmatory factor analysis were used to refine the items and factor structure based on convergence against validation measures of fatigue and sleepiness. Regression analyses were then applied to test relationships of the sleepiness and fatigue factors with sleep, mental health, and wellbeing variables. Results: An 8-item scale was developed, composed of a sleepiness (TIDI-sleepiness) and fatigue (TIDI-fatigue) factor with divergent and convergent validity, alongside a general tiredness factor. Higher TIDI-sleepiness was associated with increased apnoea risk and shorter sleep duration, whereas TIDI-fatigue was associated with increased insomnia and reduced sleep efficiency. Controlling for TIDI-sleepiness, TIDI-fatigue was associated with increased depression, anxiety, reduced well-being, and lower physical activity. Increased TIDI-sleepiness and TIDI-fatigue were both associated with paranoia and hallucinations. Conclusions: The results indicate that the TIDI can be used as a brief scale to measure and differentiate fatigue and sleepiness, particularly in non-clinical populations and for research purposes. Assessment of its validity in discriminating fatigue and sleepiness in relevant clinical sleep, mental, and physical health populations should be a focus of future research.
- Open Access
- 20 June 2026
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 201, 207-214
Testing the mediating role of negative affect, affect intolerance, and dissociation in the relationship between sleep loss and psychotic experiences
- 20 June 2026
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 201, 207-214
Open AccessTesting the mediating role of negative affect, affect intolerance, and dissociation in the relationship between sleep loss and psychotic experiences
- Open Access
- 15 July 2025
- Published by Elsevier in Psychiatry Research
- Vol. 351, 116641
The psychological consequences of the sedating side effects of antipsychotic medication: A systematic review
- 15 July 2025
- Published by Elsevier in Psychiatry Research
- Vol. 351, 116641
Open AccessThe psychological consequences of the sedating side effects of antipsychotic medication: A systematic review
- Open Access
- 2 April 2025
- Published by Wiley in British Journal of Clinical Psychology
- Vol. 65 (3) , 762-776
Understanding excessive sleep in people with psychotic disorders
Background: There has been increasing attention to sleep disturbances such as insomnia in psychosis, due to its impact on symptoms, well‐being, and recovery. However, excessive sleep and extended sleep duration are common in psychosis (partly linked to sedating antipsychotic medication) and have been relatively neglected, despite plausible interactions with symptoms, functioning, and broader well‐being. Aim: This study aimed to explore the experience of extended sleep duration and excessive sleepiness, or their combination (hypersomnia) in people with psychotic disorders through a qualitative interview around the experience, impacts, contributors, and role of treatment. Method: Ten patients experiencing excessive sleep (defined as excessive daytime sleepiness >3 days a week; extended sleep duration of > 11 h in 24 h or >9 h at night; or a combination of these) alongside a diagnosed psychotic disorder were recruited. They met with the researcher online to participate in a semi‐structured interview, which was analysed using thematic analysis. Results: Five major themes were developed: (1) The Exhausting Everyday, (2) Medication is the story? (3) Indescribable Tiredness, (4) Overruled by Sleep and (5) An Unfair Fight. Excessive sleep impacts multiple domains of individual well‐being and recovery – for example, limiting patients in everyday tasks and socializing. Cycles of emotional avoidance and inactivity were identified as potential maintainers or exacerbators of excessive sleep, in addition to medication side effects. Patients reported difficulty conveying the impact of their sleepiness symptoms to clinicians or others. Conclusion: The results support that excessive sleep requires further attention as a problematic and impactful sleep presentation in this group. Further research is needed to improve recognition and assessment of problematic excessive sleep, and how existing practices or novel treatments may be applied to reduce its impact on recovery.
- 2 April 2025
- Published by Wiley in British Journal of Clinical Psychology
- Vol. 65 (3) , 762-776
Open AccessUnderstanding excessive sleep in people with psychotic disorders
Background: There has been increasing attention to sleep disturbances such as insomnia in psychosis, due to its impact on symptoms, well‐being, and recovery. However, excessive sleep and extended sleep duration are common in psychosis (partly linked to sedating antipsychotic medication) and have been relatively neglected, despite plausible interactions with symptoms, functioning, and broader well‐being. Aim: This study aimed to explore the experience of extended sleep duration and excessive sleepiness, or their combination (hypersomnia) in people with psychotic disorders through a qualitative interview around the experience, impacts, contributors, and role of treatment. Method: Ten patients experiencing excessive sleep (defined as excessive daytime sleepiness >3 days a week; extended sleep duration of > 11 h in 24 h or >9 h at night; or a combination of these) alongside a diagnosed psychotic disorder were recruited. They met with the researcher online to participate in a semi‐structured interview, which was analysed using thematic analysis. Results: Five major themes were developed: (1) The Exhausting Everyday, (2) Medication is the story? (3) Indescribable Tiredness, (4) Overruled by Sleep and (5) An Unfair Fight. Excessive sleep impacts multiple domains of individual well‐being and recovery – for example, limiting patients in everyday tasks and socializing. Cycles of emotional avoidance and inactivity were identified as potential maintainers or exacerbators of excessive sleep, in addition to medication side effects. Patients reported difficulty conveying the impact of their sleepiness symptoms to clinicians or others. Conclusion: The results support that excessive sleep requires further attention as a problematic and impactful sleep presentation in this group. Further research is needed to improve recognition and assessment of problematic excessive sleep, and how existing practices or novel treatments may be applied to reduce its impact on recovery.
- Open Access
- 3 December 2024
- Published by BMJ in BMJ Mental Health
- Vol. 27 (1) , e301224
Potential research priorities for understanding and treating severe paranoia (persecutory delusions): a priority-setting partnership between patients, carers, mental health staff, and researchers
Background A persecutory delusion (severe paranoia) occurs when a person believes that others are trying to harm them when they are not. It is often a central difficulty for patients diagnosed with schizophrenia. Objective The objective is to identify potentially important research questions about severe paranoia. Methods A priority-setting partnership exercise was conducted involving people with lived experience, carers, mental health staff, and researchers. An initial survey identified research questions, and a second survey prioritised a refined list of questions. There was a project steering group. Findings 1480 responses were gathered from 146 people (56 people with lived experience, 23 family members, 78 mental health staff, and 21 researchers). Following refinement, 201 questions were rated by the steering group for priority to enter the second survey. 38 questions were rated in the second survey by 157 people (69 people with lived experience, 33 family members, 59 mental health staff, and 27 researchers). 15 questions were identified as research priorities, each endorsed to a largely similar extent across stakeholder groups. These covered a wide range of topics, including how to support family and carers, understanding the causes of paranoia, managing paranoid thoughts day-to-day, improving access to services, and developing psychological and pharmacological approaches. Conclusions There was a good deal of consensus in key questions—covering many aspects of understanding, treatment, and support—to be answered about severe paranoia. Most questions were considered largely equally important. Clinical implications Numerous questions were identified that, if addressed, might improve clinical provision for persecutory delusions.
- 3 December 2024
- Published by BMJ in BMJ Mental Health
- Vol. 27 (1) , e301224
Open AccessPotential research priorities for understanding and treating severe paranoia (persecutory delusions): a priority-setting partnership between patients, carers, mental health staff, and researchers
Background A persecutory delusion (severe paranoia) occurs when a person believes that others are trying to harm them when they are not. It is often a central difficulty for patients diagnosed with schizophrenia. Objective The objective is to identify potentially important research questions about severe paranoia. Methods A priority-setting partnership exercise was conducted involving people with lived experience, carers, mental health staff, and researchers. An initial survey identified research questions, and a second survey prioritised a refined list of questions. There was a project steering group. Findings 1480 responses were gathered from 146 people (56 people with lived experience, 23 family members, 78 mental health staff, and 21 researchers). Following refinement, 201 questions were rated by the steering group for priority to enter the second survey. 38 questions were rated in the second survey by 157 people (69 people with lived experience, 33 family members, 59 mental health staff, and 27 researchers). 15 questions were identified as research priorities, each endorsed to a largely similar extent across stakeholder groups. These covered a wide range of topics, including how to support family and carers, understanding the causes of paranoia, managing paranoid thoughts day-to-day, improving access to services, and developing psychological and pharmacological approaches. Conclusions There was a good deal of consensus in key questions—covering many aspects of understanding, treatment, and support—to be answered about severe paranoia. Most questions were considered largely equally important. Clinical implications Numerous questions were identified that, if addressed, might improve clinical provision for persecutory delusions.
- Open Access
- 10 September 2024
- Published by Elsevier in Sleep Medicine
- Vol. 124, 58-69
How sleep in patients with serious mental illness is recorded and treated, and its impact on service engagement
- 10 September 2024
- Published by Elsevier in Sleep Medicine
- Vol. 124, 58-69
Open AccessHow sleep in patients with serious mental illness is recorded and treated, and its impact on service engagement
- Open Access
- 27 July 2024
- Published by Elsevier in Psychiatry Research
- Vol. 339, 116111
Sleep and socio-occupational functioning in adults with serious mental illness: A systematic review
- 27 July 2024
- Published by Elsevier in Psychiatry Research
- Vol. 339, 116111
Open AccessSleep and socio-occupational functioning in adults with serious mental illness: A systematic review
- Open Access
- 16 March 2022
- Published by Springer Nature in European Child & Adolescent Psychiatry
- Vol. 32 (9) , 1609-1619
Sleep disorders predict the 1-year onset, persistence, but not remission of psychotic experiences in preadolescence: a longitudinal analysis of the ABCD cohort data
The relationship between sleep disorder and psychotic experiences in preadolescence has not been extensively studied despite the potential for intervention. The current study addressed this relationship using the Adolescent Brain and Cognitive Development (ABCD) cohort, which provided baseline data from 11,830 10- to 11-year-old; for 4910 of these, 1-year follow-up data were also available. A set of pre-registered multi-level regression models were applied to test whether (a) sleep disorder is associated with psychotic experiences at baseline; (b) baseline sleep disorder predicts psychotic experiences at follow-up; (c) the persistence of sleep disorder predicts persistence of psychotic experiences at follow-up; d) the remission of sleep disorder predicts the remission of psychotic experiences at follow-up. After controlling for potential confounders, sleep disorder was associated with psychotic experiences cross-sectionally (OR = 1.40, 95% CI 1.20–1.63), at 1-year follow-up (OR = 1.32, 95% CI 1.11–1.57), and the persistence of sleep disorder predicted the persistence of psychotic experiences (OR = 1.72, 95% CI 1.44–2.04). However, remission of sleep problems did not predict remission of psychotic experiences (OR = 1.041, 95% CI 0.80–1.35). The results indicate that sleep disorders in preadolescence are common and associated with psychotic experiences, although the lack of co-remission raises questions about the mechanism of association. However, given these findings, and existing evidence in later adolescence and adults, further investigation of sleep as a preventative mental health intervention target in this age group is warranted.
- 16 March 2022
- Published by Springer Nature in European Child & Adolescent Psychiatry
- Vol. 32 (9) , 1609-1619
Open AccessSleep disorders predict the 1-year onset, persistence, but not remission of psychotic experiences in preadolescence: a longitudinal analysis of the ABCD cohort data
The relationship between sleep disorder and psychotic experiences in preadolescence has not been extensively studied despite the potential for intervention. The current study addressed this relationship using the Adolescent Brain and Cognitive Development (ABCD) cohort, which provided baseline data from 11,830 10- to 11-year-old; for 4910 of these, 1-year follow-up data were also available. A set of pre-registered multi-level regression models were applied to test whether (a) sleep disorder is associated with psychotic experiences at baseline; (b) baseline sleep disorder predicts psychotic experiences at follow-up; (c) the persistence of sleep disorder predicts persistence of psychotic experiences at follow-up; d) the remission of sleep disorder predicts the remission of psychotic experiences at follow-up. After controlling for potential confounders, sleep disorder was associated with psychotic experiences cross-sectionally (OR = 1.40, 95% CI 1.20–1.63), at 1-year follow-up (OR = 1.32, 95% CI 1.11–1.57), and the persistence of sleep disorder predicted the persistence of psychotic experiences (OR = 1.72, 95% CI 1.44–2.04). However, remission of sleep problems did not predict remission of psychotic experiences (OR = 1.041, 95% CI 0.80–1.35). The results indicate that sleep disorders in preadolescence are common and associated with psychotic experiences, although the lack of co-remission raises questions about the mechanism of association. However, given these findings, and existing evidence in later adolescence and adults, further investigation of sleep as a preventative mental health intervention target in this age group is warranted.
- Open Access
Sleep disorders predict the one-year onset, persistence, but not remission of psychotic experiences in pre-adolescence: a longitudinal analysis of the ABCD cohort data
The relationship between sleep disorder and psychotic experiences in preadolescence has not been extensively studied despite the potential for intervention. The current study addresses this relationship using the Adolescent Brain Cognitive Development (ABCD) cohort, which provides baseline data from 11,830 10 to 11-year-olds; for 4910 of these 1-year follow-up data is also available. A set of pre-registered multi-level regression models were applied to test whether a) sleep disorder is associated with psychotic experiences at baseline; b) baseline sleep disorder predicts psychotic experiences at follow-up; c) the persistence of sleep disorder predicts persistence of psychotic experiences at follow-up; d) the remission of sleep disorder predicts the remission of psychotic experiences at follow-up. After controlling for potential confounders, sleep disorder was associated with psychotic experiences cross-sectionally (OR=1.40, 95% CI 1.20-1.63), at one-year follow-up (OR=1.32, 95% CI 1.11-1.57), and the persistence of sleep disorder predicted the persistence of psychotic experiences (OR=1.72, 95% CI 1.44-2.04). However, remission of sleep problems did not predict remission of psychotic experiences (OR=1.041, 95% CI 0.80-1.35). The results indicate that sleep disorders in preadolescence are common and associated with psychotic experiences, although the lack of co-remission raises questions about the mechanism of association. However, given these findings, and existing evidence in later adolescence and adults, further investigation of sleep as a preventative mental health intervention in this age group is warranted.
Open AccessSleep disorders predict the one-year onset, persistence, but not remission of psychotic experiences in pre-adolescence: a longitudinal analysis of the ABCD cohort data
The relationship between sleep disorder and psychotic experiences in preadolescence has not been extensively studied despite the potential for intervention. The current study addresses this relationship using the Adolescent Brain Cognitive Development (ABCD) cohort, which provides baseline data from 11,830 10 to 11-year-olds; for 4910 of these 1-year follow-up data is also available. A set of pre-registered multi-level regression models were applied to test whether a) sleep disorder is associated with psychotic experiences at baseline; b) baseline sleep disorder predicts psychotic experiences at follow-up; c) the persistence of sleep disorder predicts persistence of psychotic experiences at follow-up; d) the remission of sleep disorder predicts the remission of psychotic experiences at follow-up. After controlling for potential confounders, sleep disorder was associated with psychotic experiences cross-sectionally (OR=1.40, 95% CI 1.20-1.63), at one-year follow-up (OR=1.32, 95% CI 1.11-1.57), and the persistence of sleep disorder predicted the persistence of psychotic experiences (OR=1.72, 95% CI 1.44-2.04). However, remission of sleep problems did not predict remission of psychotic experiences (OR=1.041, 95% CI 0.80-1.35). The results indicate that sleep disorders in preadolescence are common and associated with psychotic experiences, although the lack of co-remission raises questions about the mechanism of association. However, given these findings, and existing evidence in later adolescence and adults, further investigation of sleep as a preventative mental health intervention in this age group is warranted.
- Open Access
- 15 January 2021
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 16 (1) , e0245301
Excessive sleepiness in patients with psychosis: An initial investigation
Clinical experience indicates that excessive sleepiness and hypersomnia may be a common issue for patients with psychosis. Excessive sleepiness is typically ascribed to the sedating effects of antipsychotic medications but there may be other potential contributors such as sleep disorders and depression. Furthermore, the impact of excessive sleepiness itself on patients’ symptoms and general wellbeing is yet to be examined. The current study reports an exploratory cross-sectional between-groups comparison of patients with early psychosis fulfilling criteria assessed in a diagnostic interview for problematic excessive sleepiness (n = 14), compared with those not reporting excessive sleepiness (n = 46). There were no differences between the groups in diagnosis, medication type, or antipsychotic medication dosage. There were no significant group differences in sleep duration. Significantly lower activity levels were found in the excessive sleepiness group. Insomnia and nightmares were common in those reporting excessive sleepiness. No significant differences were found in psychiatric symptoms, although data did indicate more severe cognitive disorganisation and grandiosity, but less severe paranoia and hallucinations, in the excessive sleepiness group. Wide confidence intervals and small sample size mean that care should be taken interpreting these results. Overall, this study indicates that excessive sleepiness may not be solely related to medication but also to low levels of activity and other sleep disorders. This is a novel finding that, if replicated, could indicate routes of intervention for this clinical issue. Future research should aim to disentangle directions of effect amongst sleepiness, mood, activity, and psychotic symptoms and investigate possible interventions for excessive sleepiness in psychosis.
- 15 January 2021
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 16 (1) , e0245301
Open AccessExcessive sleepiness in patients with psychosis: An initial investigation
Clinical experience indicates that excessive sleepiness and hypersomnia may be a common issue for patients with psychosis. Excessive sleepiness is typically ascribed to the sedating effects of antipsychotic medications but there may be other potential contributors such as sleep disorders and depression. Furthermore, the impact of excessive sleepiness itself on patients’ symptoms and general wellbeing is yet to be examined. The current study reports an exploratory cross-sectional between-groups comparison of patients with early psychosis fulfilling criteria assessed in a diagnostic interview for problematic excessive sleepiness (n = 14), compared with those not reporting excessive sleepiness (n = 46). There were no differences between the groups in diagnosis, medication type, or antipsychotic medication dosage. There were no significant group differences in sleep duration. Significantly lower activity levels were found in the excessive sleepiness group. Insomnia and nightmares were common in those reporting excessive sleepiness. No significant differences were found in psychiatric symptoms, although data did indicate more severe cognitive disorganisation and grandiosity, but less severe paranoia and hallucinations, in the excessive sleepiness group. Wide confidence intervals and small sample size mean that care should be taken interpreting these results. Overall, this study indicates that excessive sleepiness may not be solely related to medication but also to low levels of activity and other sleep disorders. This is a novel finding that, if replicated, could indicate routes of intervention for this clinical issue. Future research should aim to disentangle directions of effect amongst sleepiness, mood, activity, and psychotic symptoms and investigate possible interventions for excessive sleepiness in psychosis.